Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

April 01, 2022; Volume 50,Issue 4
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abduljalil, Khaled

    1. You have access
      Prediction of Maternal and Fetoplacental Concentrations of Cefazolin, Cefuroxime, and Amoxicillin during Pregnancy Using Bottom-Up Physiologically Based Pharmacokinetic Models
      Khaled Abduljalil, Jia Ning, Amita Pansari, Xian Pan and Masoud Jamei
      Drug Metabolism and Disposition April 2022, 50 (4) 386-400; DOI: https://doi.org/10.1124/dmd.121.000711
  2. Altares, R.

    1. You have access
      Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients
      P. Aviles, R. Altares, L. van Andel, R. Lubomirov, S. Fudio, H. Rosing, F. M. Márquez del Pino, M.M. Tibben, G. Benedit, L. Nan-Offeringa, X.E. Luepke Estefan, A. Francesch, A. Zeaiter, C. Cuevas, J.H.M. Schellens and J.H. Beijnen
      Drug Metabolism and Disposition April 2022, 50 (4) 327-340; DOI: https://doi.org/10.1124/dmd.121.000668
  3. Aviles, P.

    1. You have access
      Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients
      P. Aviles, R. Altares, L. van Andel, R. Lubomirov, S. Fudio, H. Rosing, F. M. Márquez del Pino, M.M. Tibben, G. Benedit, L. Nan-Offeringa, X.E. Luepke Estefan, A. Francesch, A. Zeaiter, C. Cuevas, J.H.M. Schellens and J.H. Beijnen
      Drug Metabolism and Disposition April 2022, 50 (4) 327-340; DOI: https://doi.org/10.1124/dmd.121.000668
  4. Awali, Saamera

    1. You have access
      The Complicated Role of Nuclear Factor Erythroid-Derived 2-Like 2 in Allergy and Asthma
      Cheryl E. Rockwell, Yining Jin, Allison P. Boss, Luca M. Kaiser and Saamera Awali
      Drug Metabolism and Disposition April 2022, 50 (4) 500-507; DOI: https://doi.org/10.1124/dmd.121.000414

B

  1. Backes, Wayne L.

    1. You have access
      Proteomic and Bioinformatics Analysis of Membrane Lipid Domains after Brij 98 Solubilization of Uninduced and Phenobarbital-Induced Rat Liver Microsomes: Defining the Membrane Localization of the P450 Enzyme System
      James R. Reed, Jessie J. Guidry and Wayne L. Backes
      Drug Metabolism and Disposition April 2022, 50 (4) 374-385; DOI: https://doi.org/10.1124/dmd.121.000752
  2. Badolo, Lassina

    1. Open Access
      Metabolic Profiling of S-praziquantel: Structure Elucidation Using the Crystalline Sponge Method in Combination with Mass Spectrometry and Nuclear Magnetic Resonance
      Lara Rosenberger, Judith Jenniches, Carolina von Essen, Anupam Khutia, Clemens Kühn, Andreas Marx, Katrin Georgi, Anna K. H. Hirsch, Rolf W. Hartmann and Lassina Badolo
      Drug Metabolism and Disposition April 2022, 50 (4) 320-326; DOI: https://doi.org/10.1124/dmd.121.000663
  3. Bai, Mengru

    1. You have access
      Bilirubin Reduces the Uptake of Estrogen Precursors and the Followed Synthesis of Estradiol in Human Placental Syncytiotrophoblasts via Inhibition and Downregulation of Organic Anion Transporter 4
      Yingqiong Zhang, Yujia Chen, Binxin Dai, Mengru Bai, Shuanghui Lu, Nengming Lin, Hui Zhou and Huidi Jiang
      Drug Metabolism and Disposition April 2022, 50 (4) 341-350; DOI: https://doi.org/10.1124/dmd.121.000685
  4. Bansal, Sumit

    1. You have access
      Comprehensive Predictions of Cytochrome P450 (P450)-Mediated In Vivo Cannabinoid-Drug Interactions Based on Reversible and Time-Dependent P450 Inhibition in Human Liver Microsomes
      Sumit Bansal, Mary F. Paine and Jashvant D. Unadkat
      Drug Metabolism and Disposition April 2022, 50 (4) 351-360; DOI: https://doi.org/10.1124/dmd.121.000734
  5. Beijnen, J.H.

    1. You have access
      Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients
      P. Aviles, R. Altares, L. van Andel, R. Lubomirov, S. Fudio, H. Rosing, F. M. Márquez del Pino, M.M. Tibben, G. Benedit, L. Nan-Offeringa, X.E. Luepke Estefan, A. Francesch, A. Zeaiter, C. Cuevas, J.H.M. Schellens and J.H. Beijnen
      Drug Metabolism and Disposition April 2022, 50 (4) 327-340; DOI: https://doi.org/10.1124/dmd.121.000668
  6. Benedit, G.

    1. You have access
      Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients
      P. Aviles, R. Altares, L. van Andel, R. Lubomirov, S. Fudio, H. Rosing, F. M. Márquez del Pino, M.M. Tibben, G. Benedit, L. Nan-Offeringa, X.E. Luepke Estefan, A. Francesch, A. Zeaiter, C. Cuevas, J.H.M. Schellens and J.H. Beijnen
      Drug Metabolism and Disposition April 2022, 50 (4) 327-340; DOI: https://doi.org/10.1124/dmd.121.000668
  7. Benet, Leslie Z.

    1. You have access
      Does Addition of Protein to Hepatocyte or Microsomal In Vitro Incubations Provide a Useful Improvement in In Vitro-In Vivo Extrapolation Predictability?
      Tsubasa Kameyama, Jasleen K. Sodhi and Leslie Z. Benet
      Drug Metabolism and Disposition April 2022, 50 (4) 401-412; DOI: https://doi.org/10.1124/dmd.121.000677
  8. Bhattacharya, Anisha

    1. You have access
      Environmental Chemical Contribution to the Modulation of Bile Acid Homeostasis and Farnesoid X Receptor Signaling
      Rulaiha E. Taylor, Anisha Bhattacharya and Grace L. Guo
      Drug Metabolism and Disposition April 2022, 50 (4) 456-467; DOI: https://doi.org/10.1124/dmd.121.000388
  9. Boss, Allison P.

    1. You have access
      The Complicated Role of Nuclear Factor Erythroid-Derived 2-Like 2 in Allergy and Asthma
      Cheryl E. Rockwell, Yining Jin, Allison P. Boss, Luca M. Kaiser and Saamera Awali
      Drug Metabolism and Disposition April 2022, 50 (4) 500-507; DOI: https://doi.org/10.1124/dmd.121.000414
  10. Boteju, Asela

    1. You have access
      In Vitro and In Vivo Metabolism of a Novel Antimitochondrial Cancer Metabolism Agent, CPI-613, in Rat and Human
      Vijay Bhasker Reddy, Lakmal Boteju, Asela Boteju, Li Shen, Kelem Kassahun, Nageshwar Reddy, Adrian Sheldon, Sanjeev Luther and Ke Hu
      Drug Metabolism and Disposition April 2022, 50 (4) 361-373; DOI: https://doi.org/10.1124/dmd.121.000726
  11. Boteju, Lakmal

    1. You have access
      In Vitro and In Vivo Metabolism of a Novel Antimitochondrial Cancer Metabolism Agent, CPI-613, in Rat and Human
      Vijay Bhasker Reddy, Lakmal Boteju, Asela Boteju, Li Shen, Kelem Kassahun, Nageshwar Reddy, Adrian Sheldon, Sanjeev Luther and Ke Hu
      Drug Metabolism and Disposition April 2022, 50 (4) 361-373; DOI: https://doi.org/10.1124/dmd.121.000726

C

  1. Chen, Liming

    1. You have access
      Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes
      Daniel Rizzolo, Bo Kong, Stephanie Piekos, Liming Chen, Xiaobo Zhong, Jie Lu, Jian Shi, Hao-jie Zhu, Qian Yang, Albert Li, Linhao Li, Hongbing Wang, Anna Siemiątkowska, Celine Park, Leonid Kagan and Grace L. Guo
      Drug Metabolism and Disposition April 2022, 50 (4) 468-477; DOI: https://doi.org/10.1124/dmd.121.000416
  2. Chen, Yujia

    1. You have access
      Bilirubin Reduces the Uptake of Estrogen Precursors and the Followed Synthesis of Estradiol in Human Placental Syncytiotrophoblasts via Inhibition and Downregulation of Organic Anion Transporter 4
      Yingqiong Zhang, Yujia Chen, Binxin Dai, Mengru Bai, Shuanghui Lu, Nengming Lin, Hui Zhou and Huidi Jiang
      Drug Metabolism and Disposition April 2022, 50 (4) 341-350; DOI: https://doi.org/10.1124/dmd.121.000685
  3. Cherrington, Nathan J.

    1. You have access
      Strategies to Diagnose Nonalcoholic Steatohepatitis: A Novel Approach to Take Advantage of Pharmacokinetic Alterations
      Solène Marie, David K.K. Tripp and Nathan J. Cherrington
      Drug Metabolism and Disposition April 2022, 50 (4) 492-499; DOI: https://doi.org/10.1124/dmd.121.000413
  4. Choudhuri, Supratim

    1. You have access
      Molecular Regulation of Bile Acid Homeostasis
      Supratim Choudhuri and Curtis D. Klaassen
      Drug Metabolism and Disposition April 2022, 50 (4) 425-455; DOI: https://doi.org/10.1124/dmd.121.000643
  5. Cuevas, C.

    1. You have access
      Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients
      P. Aviles, R. Altares, L. van Andel, R. Lubomirov, S. Fudio, H. Rosing, F. M. Márquez del Pino, M.M. Tibben, G. Benedit, L. Nan-Offeringa, X.E. Luepke Estefan, A. Francesch, A. Zeaiter, C. Cuevas, J.H.M. Schellens and J.H. Beijnen
      Drug Metabolism and Disposition April 2022, 50 (4) 327-340; DOI: https://doi.org/10.1124/dmd.121.000668
  6. Cui, Julia Yue

    1. You have access
      Pregnane X Receptor and the Gut-Liver Axis: A Recent Update
      Moumita Dutta, Joe Jongpyo Lim and Julia Yue Cui
      Drug Metabolism and Disposition April 2022, 50 (4) 478-491; DOI: https://doi.org/10.1124/dmd.121.000415

D

  1. Dai, Binxin

    1. You have access
      Bilirubin Reduces the Uptake of Estrogen Precursors and the Followed Synthesis of Estradiol in Human Placental Syncytiotrophoblasts via Inhibition and Downregulation of Organic Anion Transporter 4
      Yingqiong Zhang, Yujia Chen, Binxin Dai, Mengru Bai, Shuanghui Lu, Nengming Lin, Hui Zhou and Huidi Jiang
      Drug Metabolism and Disposition April 2022, 50 (4) 341-350; DOI: https://doi.org/10.1124/dmd.121.000685
  2. Dutta, Moumita

    1. You have access
      Pregnane X Receptor and the Gut-Liver Axis: A Recent Update
      Moumita Dutta, Joe Jongpyo Lim and Julia Yue Cui
      Drug Metabolism and Disposition April 2022, 50 (4) 478-491; DOI: https://doi.org/10.1124/dmd.121.000415

E

  1. Estefan, X.E. Luepke

    1. You have access
      Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients
      P. Aviles, R. Altares, L. van Andel, R. Lubomirov, S. Fudio, H. Rosing, F. M. Márquez del Pino, M.M. Tibben, G. Benedit, L. Nan-Offeringa, X.E. Luepke Estefan, A. Francesch, A. Zeaiter, C. Cuevas, J.H.M. Schellens and J.H. Beijnen
      Drug Metabolism and Disposition April 2022, 50 (4) 327-340; DOI: https://doi.org/10.1124/dmd.121.000668

F

  1. Francesch, A.

    1. You have access
      Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients
      P. Aviles, R. Altares, L. van Andel, R. Lubomirov, S. Fudio, H. Rosing, F. M. Márquez del Pino, M.M. Tibben, G. Benedit, L. Nan-Offeringa, X.E. Luepke Estefan, A. Francesch, A. Zeaiter, C. Cuevas, J.H.M. Schellens and J.H. Beijnen
      Drug Metabolism and Disposition April 2022, 50 (4) 327-340; DOI: https://doi.org/10.1124/dmd.121.000668
  2. Fudio, S.

    1. You have access
      Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients
      P. Aviles, R. Altares, L. van Andel, R. Lubomirov, S. Fudio, H. Rosing, F. M. Márquez del Pino, M.M. Tibben, G. Benedit, L. Nan-Offeringa, X.E. Luepke Estefan, A. Francesch, A. Zeaiter, C. Cuevas, J.H.M. Schellens and J.H. Beijnen
      Drug Metabolism and Disposition April 2022, 50 (4) 327-340; DOI: https://doi.org/10.1124/dmd.121.000668

G

  1. Georgi, Katrin

    1. Open Access
      Metabolic Profiling of S-praziquantel: Structure Elucidation Using the Crystalline Sponge Method in Combination with Mass Spectrometry and Nuclear Magnetic Resonance
      Lara Rosenberger, Judith Jenniches, Carolina von Essen, Anupam Khutia, Clemens Kühn, Andreas Marx, Katrin Georgi, Anna K. H. Hirsch, Rolf W. Hartmann and Lassina Badolo
      Drug Metabolism and Disposition April 2022, 50 (4) 320-326; DOI: https://doi.org/10.1124/dmd.121.000663
  2. Guidry, Jessie J.

    1. You have access
      Proteomic and Bioinformatics Analysis of Membrane Lipid Domains after Brij 98 Solubilization of Uninduced and Phenobarbital-Induced Rat Liver Microsomes: Defining the Membrane Localization of the P450 Enzyme System
      James R. Reed, Jessie J. Guidry and Wayne L. Backes
      Drug Metabolism and Disposition April 2022, 50 (4) 374-385; DOI: https://doi.org/10.1124/dmd.121.000752
  3. Guo, Grace L.

    1. You have access
      Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes
      Daniel Rizzolo, Bo Kong, Stephanie Piekos, Liming Chen, Xiaobo Zhong, Jie Lu, Jian Shi, Hao-jie Zhu, Qian Yang, Albert Li, Linhao Li, Hongbing Wang, Anna Siemiątkowska, Celine Park, Leonid Kagan and Grace L. Guo
      Drug Metabolism and Disposition April 2022, 50 (4) 468-477; DOI: https://doi.org/10.1124/dmd.121.000416
    2. You have access
      Environmental Chemical Contribution to the Modulation of Bile Acid Homeostasis and Farnesoid X Receptor Signaling
      Rulaiha E. Taylor, Anisha Bhattacharya and Grace L. Guo
      Drug Metabolism and Disposition April 2022, 50 (4) 456-467; DOI: https://doi.org/10.1124/dmd.121.000388

H

  1. Hartmann, Rolf W.

    1. Open Access
      Metabolic Profiling of S-praziquantel: Structure Elucidation Using the Crystalline Sponge Method in Combination with Mass Spectrometry and Nuclear Magnetic Resonance
      Lara Rosenberger, Judith Jenniches, Carolina von Essen, Anupam Khutia, Clemens Kühn, Andreas Marx, Katrin Georgi, Anna K. H. Hirsch, Rolf W. Hartmann and Lassina Badolo
      Drug Metabolism and Disposition April 2022, 50 (4) 320-326; DOI: https://doi.org/10.1124/dmd.121.000663
  2. Hirsch, Anna K. H.

    1. Open Access
      Metabolic Profiling of S-praziquantel: Structure Elucidation Using the Crystalline Sponge Method in Combination with Mass Spectrometry and Nuclear Magnetic Resonance
      Lara Rosenberger, Judith Jenniches, Carolina von Essen, Anupam Khutia, Clemens Kühn, Andreas Marx, Katrin Georgi, Anna K. H. Hirsch, Rolf W. Hartmann and Lassina Badolo
      Drug Metabolism and Disposition April 2022, 50 (4) 320-326; DOI: https://doi.org/10.1124/dmd.121.000663
  3. Hu, Ke

    1. You have access
      In Vitro and In Vivo Metabolism of a Novel Antimitochondrial Cancer Metabolism Agent, CPI-613, in Rat and Human
      Vijay Bhasker Reddy, Lakmal Boteju, Asela Boteju, Li Shen, Kelem Kassahun, Nageshwar Reddy, Adrian Sheldon, Sanjeev Luther and Ke Hu
      Drug Metabolism and Disposition April 2022, 50 (4) 361-373; DOI: https://doi.org/10.1124/dmd.121.000726

J

  1. Jamei, Masoud

    1. You have access
      Prediction of Maternal and Fetoplacental Concentrations of Cefazolin, Cefuroxime, and Amoxicillin during Pregnancy Using Bottom-Up Physiologically Based Pharmacokinetic Models
      Khaled Abduljalil, Jia Ning, Amita Pansari, Xian Pan and Masoud Jamei
      Drug Metabolism and Disposition April 2022, 50 (4) 386-400; DOI: https://doi.org/10.1124/dmd.121.000711
  2. Jenniches, Judith

    1. Open Access
      Metabolic Profiling of S-praziquantel: Structure Elucidation Using the Crystalline Sponge Method in Combination with Mass Spectrometry and Nuclear Magnetic Resonance
      Lara Rosenberger, Judith Jenniches, Carolina von Essen, Anupam Khutia, Clemens Kühn, Andreas Marx, Katrin Georgi, Anna K. H. Hirsch, Rolf W. Hartmann and Lassina Badolo
      Drug Metabolism and Disposition April 2022, 50 (4) 320-326; DOI: https://doi.org/10.1124/dmd.121.000663
  3. Jiang, Huidi

    1. You have access
      Bilirubin Reduces the Uptake of Estrogen Precursors and the Followed Synthesis of Estradiol in Human Placental Syncytiotrophoblasts via Inhibition and Downregulation of Organic Anion Transporter 4
      Yingqiong Zhang, Yujia Chen, Binxin Dai, Mengru Bai, Shuanghui Lu, Nengming Lin, Hui Zhou and Huidi Jiang
      Drug Metabolism and Disposition April 2022, 50 (4) 341-350; DOI: https://doi.org/10.1124/dmd.121.000685
  4. Jin, Yining

    1. You have access
      The Complicated Role of Nuclear Factor Erythroid-Derived 2-Like 2 in Allergy and Asthma
      Cheryl E. Rockwell, Yining Jin, Allison P. Boss, Luca M. Kaiser and Saamera Awali
      Drug Metabolism and Disposition April 2022, 50 (4) 500-507; DOI: https://doi.org/10.1124/dmd.121.000414

K

  1. Kagan, Leonid

    1. You have access
      Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes
      Daniel Rizzolo, Bo Kong, Stephanie Piekos, Liming Chen, Xiaobo Zhong, Jie Lu, Jian Shi, Hao-jie Zhu, Qian Yang, Albert Li, Linhao Li, Hongbing Wang, Anna Siemiątkowska, Celine Park, Leonid Kagan and Grace L. Guo
      Drug Metabolism and Disposition April 2022, 50 (4) 468-477; DOI: https://doi.org/10.1124/dmd.121.000416
  2. Kaiser, Luca M.

    1. You have access
      The Complicated Role of Nuclear Factor Erythroid-Derived 2-Like 2 in Allergy and Asthma
      Cheryl E. Rockwell, Yining Jin, Allison P. Boss, Luca M. Kaiser and Saamera Awali
      Drug Metabolism and Disposition April 2022, 50 (4) 500-507; DOI: https://doi.org/10.1124/dmd.121.000414
  3. Kameyama, Tsubasa

    1. You have access
      Does Addition of Protein to Hepatocyte or Microsomal In Vitro Incubations Provide a Useful Improvement in In Vitro-In Vivo Extrapolation Predictability?
      Tsubasa Kameyama, Jasleen K. Sodhi and Leslie Z. Benet
      Drug Metabolism and Disposition April 2022, 50 (4) 401-412; DOI: https://doi.org/10.1124/dmd.121.000677
  4. Kassahun, Kelem

    1. You have access
      In Vitro and In Vivo Metabolism of a Novel Antimitochondrial Cancer Metabolism Agent, CPI-613, in Rat and Human
      Vijay Bhasker Reddy, Lakmal Boteju, Asela Boteju, Li Shen, Kelem Kassahun, Nageshwar Reddy, Adrian Sheldon, Sanjeev Luther and Ke Hu
      Drug Metabolism and Disposition April 2022, 50 (4) 361-373; DOI: https://doi.org/10.1124/dmd.121.000726
  5. Khutia, Anupam

    1. Open Access
      Metabolic Profiling of S-praziquantel: Structure Elucidation Using the Crystalline Sponge Method in Combination with Mass Spectrometry and Nuclear Magnetic Resonance
      Lara Rosenberger, Judith Jenniches, Carolina von Essen, Anupam Khutia, Clemens Kühn, Andreas Marx, Katrin Georgi, Anna K. H. Hirsch, Rolf W. Hartmann and Lassina Badolo
      Drug Metabolism and Disposition April 2022, 50 (4) 320-326; DOI: https://doi.org/10.1124/dmd.121.000663
  6. Klaassen, Curtis D.

    1. You have access
      Molecular Regulation of Bile Acid Homeostasis
      Supratim Choudhuri and Curtis D. Klaassen
      Drug Metabolism and Disposition April 2022, 50 (4) 425-455; DOI: https://doi.org/10.1124/dmd.121.000643
  7. Kong, Bo

    1. You have access
      Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes
      Daniel Rizzolo, Bo Kong, Stephanie Piekos, Liming Chen, Xiaobo Zhong, Jie Lu, Jian Shi, Hao-jie Zhu, Qian Yang, Albert Li, Linhao Li, Hongbing Wang, Anna Siemiątkowska, Celine Park, Leonid Kagan and Grace L. Guo
      Drug Metabolism and Disposition April 2022, 50 (4) 468-477; DOI: https://doi.org/10.1124/dmd.121.000416
  8. Kühn, Clemens

    1. Open Access
      Metabolic Profiling of S-praziquantel: Structure Elucidation Using the Crystalline Sponge Method in Combination with Mass Spectrometry and Nuclear Magnetic Resonance
      Lara Rosenberger, Judith Jenniches, Carolina von Essen, Anupam Khutia, Clemens Kühn, Andreas Marx, Katrin Georgi, Anna K. H. Hirsch, Rolf W. Hartmann and Lassina Badolo
      Drug Metabolism and Disposition April 2022, 50 (4) 320-326; DOI: https://doi.org/10.1124/dmd.121.000663

L

  1. Li, Albert

    1. You have access
      Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes
      Daniel Rizzolo, Bo Kong, Stephanie Piekos, Liming Chen, Xiaobo Zhong, Jie Lu, Jian Shi, Hao-jie Zhu, Qian Yang, Albert Li, Linhao Li, Hongbing Wang, Anna Siemiątkowska, Celine Park, Leonid Kagan and Grace L. Guo
      Drug Metabolism and Disposition April 2022, 50 (4) 468-477; DOI: https://doi.org/10.1124/dmd.121.000416
  2. Li, Linhao

    1. You have access
      Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes
      Daniel Rizzolo, Bo Kong, Stephanie Piekos, Liming Chen, Xiaobo Zhong, Jie Lu, Jian Shi, Hao-jie Zhu, Qian Yang, Albert Li, Linhao Li, Hongbing Wang, Anna Siemiątkowska, Celine Park, Leonid Kagan and Grace L. Guo
      Drug Metabolism and Disposition April 2022, 50 (4) 468-477; DOI: https://doi.org/10.1124/dmd.121.000416
  3. Lim, Joe Jongpyo

    1. You have access
      Pregnane X Receptor and the Gut-Liver Axis: A Recent Update
      Moumita Dutta, Joe Jongpyo Lim and Julia Yue Cui
      Drug Metabolism and Disposition April 2022, 50 (4) 478-491; DOI: https://doi.org/10.1124/dmd.121.000415
  4. Lin, Nengming

    1. You have access
      Bilirubin Reduces the Uptake of Estrogen Precursors and the Followed Synthesis of Estradiol in Human Placental Syncytiotrophoblasts via Inhibition and Downregulation of Organic Anion Transporter 4
      Yingqiong Zhang, Yujia Chen, Binxin Dai, Mengru Bai, Shuanghui Lu, Nengming Lin, Hui Zhou and Huidi Jiang
      Drug Metabolism and Disposition April 2022, 50 (4) 341-350; DOI: https://doi.org/10.1124/dmd.121.000685
  5. Lu, Jie

    1. You have access
      Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes
      Daniel Rizzolo, Bo Kong, Stephanie Piekos, Liming Chen, Xiaobo Zhong, Jie Lu, Jian Shi, Hao-jie Zhu, Qian Yang, Albert Li, Linhao Li, Hongbing Wang, Anna Siemiątkowska, Celine Park, Leonid Kagan and Grace L. Guo
      Drug Metabolism and Disposition April 2022, 50 (4) 468-477; DOI: https://doi.org/10.1124/dmd.121.000416
  6. Lu, Shuanghui

    1. You have access
      Bilirubin Reduces the Uptake of Estrogen Precursors and the Followed Synthesis of Estradiol in Human Placental Syncytiotrophoblasts via Inhibition and Downregulation of Organic Anion Transporter 4
      Yingqiong Zhang, Yujia Chen, Binxin Dai, Mengru Bai, Shuanghui Lu, Nengming Lin, Hui Zhou and Huidi Jiang
      Drug Metabolism and Disposition April 2022, 50 (4) 341-350; DOI: https://doi.org/10.1124/dmd.121.000685
  7. Lubomirov, R.

    1. You have access
      Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients
      P. Aviles, R. Altares, L. van Andel, R. Lubomirov, S. Fudio, H. Rosing, F. M. Márquez del Pino, M.M. Tibben, G. Benedit, L. Nan-Offeringa, X.E. Luepke Estefan, A. Francesch, A. Zeaiter, C. Cuevas, J.H.M. Schellens and J.H. Beijnen
      Drug Metabolism and Disposition April 2022, 50 (4) 327-340; DOI: https://doi.org/10.1124/dmd.121.000668
  8. Luther, Sanjeev

    1. You have access
      In Vitro and In Vivo Metabolism of a Novel Antimitochondrial Cancer Metabolism Agent, CPI-613, in Rat and Human
      Vijay Bhasker Reddy, Lakmal Boteju, Asela Boteju, Li Shen, Kelem Kassahun, Nageshwar Reddy, Adrian Sheldon, Sanjeev Luther and Ke Hu
      Drug Metabolism and Disposition April 2022, 50 (4) 361-373; DOI: https://doi.org/10.1124/dmd.121.000726

M

  1. Marie, Solène

    1. You have access
      Strategies to Diagnose Nonalcoholic Steatohepatitis: A Novel Approach to Take Advantage of Pharmacokinetic Alterations
      Solène Marie, David K.K. Tripp and Nathan J. Cherrington
      Drug Metabolism and Disposition April 2022, 50 (4) 492-499; DOI: https://doi.org/10.1124/dmd.121.000413
  2. Márquez del Pino, F. M.

    1. You have access
      Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients
      P. Aviles, R. Altares, L. van Andel, R. Lubomirov, S. Fudio, H. Rosing, F. M. Márquez del Pino, M.M. Tibben, G. Benedit, L. Nan-Offeringa, X.E. Luepke Estefan, A. Francesch, A. Zeaiter, C. Cuevas, J.H.M. Schellens and J.H. Beijnen
      Drug Metabolism and Disposition April 2022, 50 (4) 327-340; DOI: https://doi.org/10.1124/dmd.121.000668
  3. Marx, Andreas

    1. Open Access
      Metabolic Profiling of S-praziquantel: Structure Elucidation Using the Crystalline Sponge Method in Combination with Mass Spectrometry and Nuclear Magnetic Resonance
      Lara Rosenberger, Judith Jenniches, Carolina von Essen, Anupam Khutia, Clemens Kühn, Andreas Marx, Katrin Georgi, Anna K. H. Hirsch, Rolf W. Hartmann and Lassina Badolo
      Drug Metabolism and Disposition April 2022, 50 (4) 320-326; DOI: https://doi.org/10.1124/dmd.121.000663

N

  1. Nan-Offeringa, L.

    1. You have access
      Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients
      P. Aviles, R. Altares, L. van Andel, R. Lubomirov, S. Fudio, H. Rosing, F. M. Márquez del Pino, M.M. Tibben, G. Benedit, L. Nan-Offeringa, X.E. Luepke Estefan, A. Francesch, A. Zeaiter, C. Cuevas, J.H.M. Schellens and J.H. Beijnen
      Drug Metabolism and Disposition April 2022, 50 (4) 327-340; DOI: https://doi.org/10.1124/dmd.121.000668
  2. Ning, Jia

    1. You have access
      Prediction of Maternal and Fetoplacental Concentrations of Cefazolin, Cefuroxime, and Amoxicillin during Pregnancy Using Bottom-Up Physiologically Based Pharmacokinetic Models
      Khaled Abduljalil, Jia Ning, Amita Pansari, Xian Pan and Masoud Jamei
      Drug Metabolism and Disposition April 2022, 50 (4) 386-400; DOI: https://doi.org/10.1124/dmd.121.000711

O

  1. Obach, R. Scott

    1. You have access
      Linezolid Metabolism Is Catalyzed by Cytochrome P450 2J2, 4F2, and 1B1
      R. Scott Obach
      Drug Metabolism and Disposition April 2022, 50 (4) 413-421; DOI: https://doi.org/10.1124/dmd.121.000776

P

  1. Paine, Mary F.

    1. You have access
      Comprehensive Predictions of Cytochrome P450 (P450)-Mediated In Vivo Cannabinoid-Drug Interactions Based on Reversible and Time-Dependent P450 Inhibition in Human Liver Microsomes
      Sumit Bansal, Mary F. Paine and Jashvant D. Unadkat
      Drug Metabolism and Disposition April 2022, 50 (4) 351-360; DOI: https://doi.org/10.1124/dmd.121.000734
  2. Pan, Xian

    1. You have access
      Prediction of Maternal and Fetoplacental Concentrations of Cefazolin, Cefuroxime, and Amoxicillin during Pregnancy Using Bottom-Up Physiologically Based Pharmacokinetic Models
      Khaled Abduljalil, Jia Ning, Amita Pansari, Xian Pan and Masoud Jamei
      Drug Metabolism and Disposition April 2022, 50 (4) 386-400; DOI: https://doi.org/10.1124/dmd.121.000711
  3. Pansari, Amita

    1. You have access
      Prediction of Maternal and Fetoplacental Concentrations of Cefazolin, Cefuroxime, and Amoxicillin during Pregnancy Using Bottom-Up Physiologically Based Pharmacokinetic Models
      Khaled Abduljalil, Jia Ning, Amita Pansari, Xian Pan and Masoud Jamei
      Drug Metabolism and Disposition April 2022, 50 (4) 386-400; DOI: https://doi.org/10.1124/dmd.121.000711
  4. Park, Celine

    1. You have access
      Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes
      Daniel Rizzolo, Bo Kong, Stephanie Piekos, Liming Chen, Xiaobo Zhong, Jie Lu, Jian Shi, Hao-jie Zhu, Qian Yang, Albert Li, Linhao Li, Hongbing Wang, Anna Siemiątkowska, Celine Park, Leonid Kagan and Grace L. Guo
      Drug Metabolism and Disposition April 2022, 50 (4) 468-477; DOI: https://doi.org/10.1124/dmd.121.000416
  5. Piekos, Stephanie

    1. You have access
      Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes
      Daniel Rizzolo, Bo Kong, Stephanie Piekos, Liming Chen, Xiaobo Zhong, Jie Lu, Jian Shi, Hao-jie Zhu, Qian Yang, Albert Li, Linhao Li, Hongbing Wang, Anna Siemiątkowska, Celine Park, Leonid Kagan and Grace L. Guo
      Drug Metabolism and Disposition April 2022, 50 (4) 468-477; DOI: https://doi.org/10.1124/dmd.121.000416

R

  1. Reddy, Nageshwar

    1. You have access
      In Vitro and In Vivo Metabolism of a Novel Antimitochondrial Cancer Metabolism Agent, CPI-613, in Rat and Human
      Vijay Bhasker Reddy, Lakmal Boteju, Asela Boteju, Li Shen, Kelem Kassahun, Nageshwar Reddy, Adrian Sheldon, Sanjeev Luther and Ke Hu
      Drug Metabolism and Disposition April 2022, 50 (4) 361-373; DOI: https://doi.org/10.1124/dmd.121.000726
  2. Reddy, Vijay Bhasker

    1. You have access
      In Vitro and In Vivo Metabolism of a Novel Antimitochondrial Cancer Metabolism Agent, CPI-613, in Rat and Human
      Vijay Bhasker Reddy, Lakmal Boteju, Asela Boteju, Li Shen, Kelem Kassahun, Nageshwar Reddy, Adrian Sheldon, Sanjeev Luther and Ke Hu
      Drug Metabolism and Disposition April 2022, 50 (4) 361-373; DOI: https://doi.org/10.1124/dmd.121.000726
  3. Reed, James R.

    1. You have access
      Proteomic and Bioinformatics Analysis of Membrane Lipid Domains after Brij 98 Solubilization of Uninduced and Phenobarbital-Induced Rat Liver Microsomes: Defining the Membrane Localization of the P450 Enzyme System
      James R. Reed, Jessie J. Guidry and Wayne L. Backes
      Drug Metabolism and Disposition April 2022, 50 (4) 374-385; DOI: https://doi.org/10.1124/dmd.121.000752
  4. Rizzolo, Daniel

    1. You have access
      Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes
      Daniel Rizzolo, Bo Kong, Stephanie Piekos, Liming Chen, Xiaobo Zhong, Jie Lu, Jian Shi, Hao-jie Zhu, Qian Yang, Albert Li, Linhao Li, Hongbing Wang, Anna Siemiątkowska, Celine Park, Leonid Kagan and Grace L. Guo
      Drug Metabolism and Disposition April 2022, 50 (4) 468-477; DOI: https://doi.org/10.1124/dmd.121.000416
  5. Rockwell, Cheryl E.

    1. You have access
      The Complicated Role of Nuclear Factor Erythroid-Derived 2-Like 2 in Allergy and Asthma
      Cheryl E. Rockwell, Yining Jin, Allison P. Boss, Luca M. Kaiser and Saamera Awali
      Drug Metabolism and Disposition April 2022, 50 (4) 500-507; DOI: https://doi.org/10.1124/dmd.121.000414
  6. Rosenberger, Lara

    1. Open Access
      Metabolic Profiling of S-praziquantel: Structure Elucidation Using the Crystalline Sponge Method in Combination with Mass Spectrometry and Nuclear Magnetic Resonance
      Lara Rosenberger, Judith Jenniches, Carolina von Essen, Anupam Khutia, Clemens Kühn, Andreas Marx, Katrin Georgi, Anna K. H. Hirsch, Rolf W. Hartmann and Lassina Badolo
      Drug Metabolism and Disposition April 2022, 50 (4) 320-326; DOI: https://doi.org/10.1124/dmd.121.000663
  7. Rosing, H.

    1. You have access
      Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients
      P. Aviles, R. Altares, L. van Andel, R. Lubomirov, S. Fudio, H. Rosing, F. M. Márquez del Pino, M.M. Tibben, G. Benedit, L. Nan-Offeringa, X.E. Luepke Estefan, A. Francesch, A. Zeaiter, C. Cuevas, J.H.M. Schellens and J.H. Beijnen
      Drug Metabolism and Disposition April 2022, 50 (4) 327-340; DOI: https://doi.org/10.1124/dmd.121.000668

S

  1. Schellens, J.H.M.

    1. You have access
      Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients
      P. Aviles, R. Altares, L. van Andel, R. Lubomirov, S. Fudio, H. Rosing, F. M. Márquez del Pino, M.M. Tibben, G. Benedit, L. Nan-Offeringa, X.E. Luepke Estefan, A. Francesch, A. Zeaiter, C. Cuevas, J.H.M. Schellens and J.H. Beijnen
      Drug Metabolism and Disposition April 2022, 50 (4) 327-340; DOI: https://doi.org/10.1124/dmd.121.000668
  2. Sheldon, Adrian

    1. You have access
      In Vitro and In Vivo Metabolism of a Novel Antimitochondrial Cancer Metabolism Agent, CPI-613, in Rat and Human
      Vijay Bhasker Reddy, Lakmal Boteju, Asela Boteju, Li Shen, Kelem Kassahun, Nageshwar Reddy, Adrian Sheldon, Sanjeev Luther and Ke Hu
      Drug Metabolism and Disposition April 2022, 50 (4) 361-373; DOI: https://doi.org/10.1124/dmd.121.000726
  3. Shen, Li

    1. You have access
      In Vitro and In Vivo Metabolism of a Novel Antimitochondrial Cancer Metabolism Agent, CPI-613, in Rat and Human
      Vijay Bhasker Reddy, Lakmal Boteju, Asela Boteju, Li Shen, Kelem Kassahun, Nageshwar Reddy, Adrian Sheldon, Sanjeev Luther and Ke Hu
      Drug Metabolism and Disposition April 2022, 50 (4) 361-373; DOI: https://doi.org/10.1124/dmd.121.000726
  4. Shi, Jian

    1. You have access
      Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes
      Daniel Rizzolo, Bo Kong, Stephanie Piekos, Liming Chen, Xiaobo Zhong, Jie Lu, Jian Shi, Hao-jie Zhu, Qian Yang, Albert Li, Linhao Li, Hongbing Wang, Anna Siemiątkowska, Celine Park, Leonid Kagan and Grace L. Guo
      Drug Metabolism and Disposition April 2022, 50 (4) 468-477; DOI: https://doi.org/10.1124/dmd.121.000416
  5. Siemiątkowska, Anna

    1. You have access
      Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes
      Daniel Rizzolo, Bo Kong, Stephanie Piekos, Liming Chen, Xiaobo Zhong, Jie Lu, Jian Shi, Hao-jie Zhu, Qian Yang, Albert Li, Linhao Li, Hongbing Wang, Anna Siemiątkowska, Celine Park, Leonid Kagan and Grace L. Guo
      Drug Metabolism and Disposition April 2022, 50 (4) 468-477; DOI: https://doi.org/10.1124/dmd.121.000416
  6. Sodhi, Jasleen K.

    1. You have access
      Does Addition of Protein to Hepatocyte or Microsomal In Vitro Incubations Provide a Useful Improvement in In Vitro-In Vivo Extrapolation Predictability?
      Tsubasa Kameyama, Jasleen K. Sodhi and Leslie Z. Benet
      Drug Metabolism and Disposition April 2022, 50 (4) 401-412; DOI: https://doi.org/10.1124/dmd.121.000677

T

  1. Taylor, Rulaiha E.

    1. You have access
      Environmental Chemical Contribution to the Modulation of Bile Acid Homeostasis and Farnesoid X Receptor Signaling
      Rulaiha E. Taylor, Anisha Bhattacharya and Grace L. Guo
      Drug Metabolism and Disposition April 2022, 50 (4) 456-467; DOI: https://doi.org/10.1124/dmd.121.000388
  2. Tibben, M.M.

    1. You have access
      Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients
      P. Aviles, R. Altares, L. van Andel, R. Lubomirov, S. Fudio, H. Rosing, F. M. Márquez del Pino, M.M. Tibben, G. Benedit, L. Nan-Offeringa, X.E. Luepke Estefan, A. Francesch, A. Zeaiter, C. Cuevas, J.H.M. Schellens and J.H. Beijnen
      Drug Metabolism and Disposition April 2022, 50 (4) 327-340; DOI: https://doi.org/10.1124/dmd.121.000668
  3. Tripp, David K.K.

    1. You have access
      Strategies to Diagnose Nonalcoholic Steatohepatitis: A Novel Approach to Take Advantage of Pharmacokinetic Alterations
      Solène Marie, David K.K. Tripp and Nathan J. Cherrington
      Drug Metabolism and Disposition April 2022, 50 (4) 492-499; DOI: https://doi.org/10.1124/dmd.121.000413

U

  1. Unadkat, Jashvant D.

    1. You have access
      Comprehensive Predictions of Cytochrome P450 (P450)-Mediated In Vivo Cannabinoid-Drug Interactions Based on Reversible and Time-Dependent P450 Inhibition in Human Liver Microsomes
      Sumit Bansal, Mary F. Paine and Jashvant D. Unadkat
      Drug Metabolism and Disposition April 2022, 50 (4) 351-360; DOI: https://doi.org/10.1124/dmd.121.000734

V

  1. van Andel, L.

    1. You have access
      Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients
      P. Aviles, R. Altares, L. van Andel, R. Lubomirov, S. Fudio, H. Rosing, F. M. Márquez del Pino, M.M. Tibben, G. Benedit, L. Nan-Offeringa, X.E. Luepke Estefan, A. Francesch, A. Zeaiter, C. Cuevas, J.H.M. Schellens and J.H. Beijnen
      Drug Metabolism and Disposition April 2022, 50 (4) 327-340; DOI: https://doi.org/10.1124/dmd.121.000668
  2. Vansell, Nichole R.

    1. Open Access
      Mechanisms by Which Inducers of Drug Metabolizing Enzymes Alter Thyroid Hormones in Rats
      Nichole R. Vansell
      Drug Metabolism and Disposition April 2022, 50 (4) 508-517; DOI: https://doi.org/10.1124/dmd.121.000498
  3. von Essen, Carolina

    1. Open Access
      Metabolic Profiling of S-praziquantel: Structure Elucidation Using the Crystalline Sponge Method in Combination with Mass Spectrometry and Nuclear Magnetic Resonance
      Lara Rosenberger, Judith Jenniches, Carolina von Essen, Anupam Khutia, Clemens Kühn, Andreas Marx, Katrin Georgi, Anna K. H. Hirsch, Rolf W. Hartmann and Lassina Badolo
      Drug Metabolism and Disposition April 2022, 50 (4) 320-326; DOI: https://doi.org/10.1124/dmd.121.000663

W

  1. Wang, Hongbing

    1. You have access
      Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes
      Daniel Rizzolo, Bo Kong, Stephanie Piekos, Liming Chen, Xiaobo Zhong, Jie Lu, Jian Shi, Hao-jie Zhu, Qian Yang, Albert Li, Linhao Li, Hongbing Wang, Anna Siemiątkowska, Celine Park, Leonid Kagan and Grace L. Guo
      Drug Metabolism and Disposition April 2022, 50 (4) 468-477; DOI: https://doi.org/10.1124/dmd.121.000416

Y

  1. Yang, Qian

    1. You have access
      Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes
      Daniel Rizzolo, Bo Kong, Stephanie Piekos, Liming Chen, Xiaobo Zhong, Jie Lu, Jian Shi, Hao-jie Zhu, Qian Yang, Albert Li, Linhao Li, Hongbing Wang, Anna Siemiątkowska, Celine Park, Leonid Kagan and Grace L. Guo
      Drug Metabolism and Disposition April 2022, 50 (4) 468-477; DOI: https://doi.org/10.1124/dmd.121.000416

Z

  1. Zeaiter, A.

    1. You have access
      Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients
      P. Aviles, R. Altares, L. van Andel, R. Lubomirov, S. Fudio, H. Rosing, F. M. Márquez del Pino, M.M. Tibben, G. Benedit, L. Nan-Offeringa, X.E. Luepke Estefan, A. Francesch, A. Zeaiter, C. Cuevas, J.H.M. Schellens and J.H. Beijnen
      Drug Metabolism and Disposition April 2022, 50 (4) 327-340; DOI: https://doi.org/10.1124/dmd.121.000668
  2. Zhang, Yingqiong

    1. You have access
      Bilirubin Reduces the Uptake of Estrogen Precursors and the Followed Synthesis of Estradiol in Human Placental Syncytiotrophoblasts via Inhibition and Downregulation of Organic Anion Transporter 4
      Yingqiong Zhang, Yujia Chen, Binxin Dai, Mengru Bai, Shuanghui Lu, Nengming Lin, Hui Zhou and Huidi Jiang
      Drug Metabolism and Disposition April 2022, 50 (4) 341-350; DOI: https://doi.org/10.1124/dmd.121.000685
  3. Zhong, Xiaobo

    1. You have access
      Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes
      Daniel Rizzolo, Bo Kong, Stephanie Piekos, Liming Chen, Xiaobo Zhong, Jie Lu, Jian Shi, Hao-jie Zhu, Qian Yang, Albert Li, Linhao Li, Hongbing Wang, Anna Siemiątkowska, Celine Park, Leonid Kagan and Grace L. Guo
      Drug Metabolism and Disposition April 2022, 50 (4) 468-477; DOI: https://doi.org/10.1124/dmd.121.000416
  4. Zhou, Hui

    1. You have access
      Bilirubin Reduces the Uptake of Estrogen Precursors and the Followed Synthesis of Estradiol in Human Placental Syncytiotrophoblasts via Inhibition and Downregulation of Organic Anion Transporter 4
      Yingqiong Zhang, Yujia Chen, Binxin Dai, Mengru Bai, Shuanghui Lu, Nengming Lin, Hui Zhou and Huidi Jiang
      Drug Metabolism and Disposition April 2022, 50 (4) 341-350; DOI: https://doi.org/10.1124/dmd.121.000685
  5. Zhu, Hao-jie

    1. You have access
      Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes
      Daniel Rizzolo, Bo Kong, Stephanie Piekos, Liming Chen, Xiaobo Zhong, Jie Lu, Jian Shi, Hao-jie Zhu, Qian Yang, Albert Li, Linhao Li, Hongbing Wang, Anna Siemiątkowska, Celine Park, Leonid Kagan and Grace L. Guo
      Drug Metabolism and Disposition April 2022, 50 (4) 468-477; DOI: https://doi.org/10.1124/dmd.121.000416
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 50 (4)
Drug Metabolism and Disposition
Vol. 50, Issue 4
1 Apr 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics